Clinical features of non-syndromic familial phaeochromocytoma
Irene A. Aligianis(Institute of Genetics and Cancer), ER Maher, D. W. Evans, Fiona Douglas(University of Southern California), SV Hodgson, J. M. C. Connell(University of Glasgow), P. E. Morrison(NHS Highland), E George
Unknown
January 1, 2000
Cited by 0
Related Papers
Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma
|The American Journal of Human Genetics|2001|1.1k
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
|JNCI Journal of the National Cancer Institute|2013|946
Germline <i>BRCA</i> Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
|Journal of Clinical Oncology|2013|833
Germline mutations in RAD51D confer susceptibility to ovarian cancer
|Nature Genetics|2011|545